Importantly, pharmacological inhibition of DHODH with agents such as brequinar or leflunomide resensitizes resistant cells to chemotherapy, suggesting that targeting DHODH could serve as a strategy to overcome resistance in multiple tumor types [17,72,75,76]. The gene discussed is DHODH; the disease is neoplasm.